February 16, 2017
Valeant wins FDA’s approval for psoriasis drug
The U.S. Food and Drug Administration (FDA) has approved Valeant Pharmaceuticals’s Siliq (brodalumab) to treat adults with moderate-to-severe plaque psoriasis.
Pharmaceuticals, Biotechnology and Life Sciences
Tag: Siliq